CLASS II ONGOING Device recall · Reported 8 May 2024 · FDA Enforcement Report

Keller Funnel recalled by Allergan Sales

Allergan Sales is recalling Keller Funnel 2, distributed nationwide in the US. The recall was initiated on 14 Mar 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 10888628043725 / Lot #: 23B35C, 23B41C, 23B42C, 23C05C, 23C06C, 23D01C, 24C12C
Quantity recalled10837

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1694-2024
FDA event ID
94287
Recalling firm
Allergan Sales, Irvine, CA
Classification
Class II
Status
Ongoing
Recall initiated
14 Mar 2024
FDA classified
29 Apr 2024
Reported
8 May 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

14 Mar 2024Recall initiated by company
29 Apr 2024Classified by FDA+46 days
8 May 2024Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Their is a potential that breast implants lack the lubricious coating that allows them to slide through the funnels during the implantation procedure.

Product as listed by the FDA

Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only,

Where it was distributed

US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY.

Nationwide AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusetts

Questions about this recall

Why was it recalled?

Their is a potential that breast implants lack the lubricious coating that allows them to slide through the funnels during the implantation procedure.

Which lots are affected?

UDI: 10888628043725 / Lot #: 23B35C, 23B41C, 23B42C, 23C05C, 23C06C, 23D01C, 24C12C

Where was it sold?

US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Allergan Sales

All 14

Other Other Medical Devices recalls

All 13,884